Please login to the form below
non-steroidal therapy
This page shows the latest non-steroidal therapy news and features for those working in and with pharma, biotech and healthcare.
Roche out-licenses lebrikizumab rights to Dermira
Other competition is also in the offing including GlaxoSmithKline's asthma therapy Nucala (mepolizumab) and non-steroidal anti-inflammatory tapinarof, which are both in mid-stage testing for atopic dermatitis, and
Latest news
-
FDA green light for Pfizer's eczema drug
Pfizer's blockbuster-in-waiting Eucrisa has been approved by the FDA for eczema, becoming the first non-steroidal therapy for the skin condition in more than 15 years.
-
Pfizer adds eczema drug with $5.2bn Anacor acquisition
Pfizer adds eczema drug with $5.2bn Anacor acquisition. Expands innovative products business with non-steroidal therapy Crisaborole. ... and if approved would be the first new non-steroidal therapy for the skin condition in more than 15 years.
-
Novartis wins childhood arthritis indication for Ilaris in EU
Ilaris gains a new indication as a monthly subcutaneous injection in patients aged two years and older who have not responded to therapy with non-steroidal anti-inflammatory drugs (NSAIDs) and ... The approval] represents another significant milestone in
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- NHS England says yes to Roche's Hemlibra
- Moving annual total (MAT)
- Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Communiqué Awards 2018: Winners in pictures - Communiqué Awards 2016
- Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use
- ‘Common Rulebook’ Brexit plans include medicines – but face backlash
- MaxCyte gets green light for solid tumour cell therapy
- Novartis rejects claims it misled Senate over Cohen links
- May’s Brexit plan cautiously welcomed by biopharma sector
- Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan
PMHub
Hive
We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...
Latest intelligence
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
- The rise of vertical integration in the US payer landscape
- Is it a solution to addressing the challenges of the value-based marketplace?...
- Creativity has lost its worth
- Creativity has lost its worth, and sadly it is undermining effectiveness...
Quick links
Infographics
